Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gregory John Hollingworth is active.

Publication


Featured researches published by Gregory John Hollingworth.


Journal of Pharmacology and Experimental Therapeutics | 2002

Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4-Hydroxy-5-iodo-3-methoxyphenylacetate ester) Iodo-Resiniferatoxin

Guy R. Seabrook; Kathy Sutton; Wolfgang Jarolimek; Gregory John Hollingworth; Simon Teague; J.K. Webb; Natalie Clark; Susan Boyce; Julie Kerby; Zahid Ali; Margaret Z. Chou; Richard E. Middleton; Gregory J. Kaczorowski; A. Brian Jones

We have synthesized iodinated resiniferatoxin bearing a 4-hydroxy-5-iodo-3-methoxyphenylacetate ester (I-RTX) and have characterized its activity on rat and human TRPV1 (VR1) receptors, as well as in behavioral assays of nociception. In whole cell patch-clamp recordings from transfected cells the functional activity of I-RTX was determined. Currents activated by capsaicin exhibited characteristic outward rectification and were antagonized by capsazepine and I-RTX. On rat TRPV1 the affinity of I-RTX was 800-fold higher than that of capsazepine (IC50 = 0.7 and 562 nM, respectively) and 10-fold higher on rat versus human receptors (IC50 = 0.7 and 5.4 nM, respectively). The same difference was observed when comparing the inhibition of [3H]RTX binding to rat and human TRPV1 membranes for both RTX and I-RTX. Additional pharmacological differences were revealed using protons as the stimulus. Under these conditions capsazepine only partly blocked currents through rat TRPV1 receptors (by 70 to 80% block), yet was a full antagonist on human receptors. In contrast, I-RTX completely blocked proton-induced currents in both species and that activated by noxious heat. I-RTX also blocked capsaicin-induced firing of C-fibers in a rat in vitro skin-nerve assay. Despite this activity and the high affinity of I-RTX for rat TRPV1, only capsazepine proved to be an effective antagonist of capsaicin-induced paw flinching in rats. Thus, although I-RTX has limited utility for in vivo behavioral studies it is a high-affinity TRPV1 receptor antagonist that will be useful to characterize the functional properties of cloned and native vanilloid receptor subtypes in vitro.


Bioorganic & Medicinal Chemistry Letters | 2001

2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution

Laura Catherine Cooper; Gary G. Chicchi; Kevin Dinnell; Jason Matthew Elliott; Gregory John Hollingworth; Marc M. Kurtz; Karen L Locker; Denise Morrison; Duncan E. Shaw; Kwei-Lan Tsao; Alan P. Watt; Angela R. Williams; Christopher John Swain

The synthesis and biological evaluation of a series of 2-aryl indoles with high affinity for the human neurokinin-1 (hNK1) receptor are reported, concentrating on optimisation of the indole substitution.


Bioorganic & Medicinal Chemistry Letters | 2001

2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent

Kevin Dinnell; Gary G. Chicchi; Madhumeeta J Dhar; Jason Matthew Elliott; Gregory John Hollingworth; Marc M. Kurtz; Mark Peter Ridgill; Wayne Rycroft; Kwei-Lan Tsao; Angela R. Williams; Christopher John Swain

Novel 2-aryl indole hNK1 receptor ligands were prepared utilising palladium cross-coupling chemistry of a late intermediate as a key step. Compounds with high hNK1 receptor binding affinity and good brain penetration (e.g., 9d) were synthesised.


Tetrahedron Letters | 1999

A convenient method for the preparation of aryl cyclopropyl ethers from phenols

Gregory John Hollingworth; Kevin Dinnell; Laura C. Dickinson; Jason Matthew Elliott; Janusz Jozef Kulagowski; Christopher John Swain; Christopher G. Thomson

Abstract A general method for the synthesis of cyclopropyl ethers from phenols is described. Alkylation of a phenol using 1-iodo-1-(phenylthio)cyclopropane followed by removal of the phenylthio group furnishes the cyclopropyl ethers in modest to excellent yields. The procedure tolerates a wide range of functional groups.


Bioorganic & Medicinal Chemistry Letters | 2002

4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II

Jason Matthew Elliott; José L. Castro; Gary G. Chicchi; Laura Catherine Cooper; Kevin Dinnell; Gregory John Hollingworth; Mark Peter Ridgill; Wayne Rycroft; Marc M. Kurtz; Duncan E. Shaw; Christopher John Swain; Kwei-Lan Tsao; Lihu Yang

Abstract A series of novel 4,4-disubstituted cyclohexylamine based NK 1 antagonists is described. The effect of changes to the C 1 –C 4 relative stereochemistry on the cyclohexane ring and replacements for the flexible linker are discussed, leading to the identification of compounds with high affinity and good in vivo duration of action.


Archive | 1998

Spiro-azacyclic derivatives and their use as therapeutic agents

Neil Roy Curtis; Jason Matthew Elliott; Gregory John Hollingworth; Philips Stephen Jackson; Janusz Jozef Kulagowski; Eileen Mary Seward; Christopher John Swain; Brian John Williams


Archive | 2003

Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain

Rebecca Elizabeth Brown; Victoria Alexandra Doughty; Gregory John Hollingworth; A. Brian Jones; Matthew John Lindon; Christopher Richard Moyes; Lauren Rogers


Archive | 1997

Spiro-piperidine derivatives and their use as therapeutic agents

Raymond Baker; Neil Roy Curtis; Jason Matthew Elliott; Timothy Harrison; Gregory John Hollingworth; Philip Stephen Jackson; Janusz Jozef Kulagowski; Eileen Mary Seward; Christopher John Swain; Brian John Williams


Archive | 2001

2-aryl indole derivatives and their use as therapeutic agents

Kevin Dinnell; Jason Matthew Elliott; Gregory John Hollingworth; Mark Peter Ridgill; Duncan Edward Shaw


Archive | 2004

Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain

Stephen Robert Fletcher; Gregory John Hollingworth; A. Brian Jones; Christopher Richard Moyes; Lauren Rogers

Collaboration


Dive into the Gregory John Hollingworth's collaboration.

Researchain Logo
Decentralizing Knowledge